Elsevier

Life Sciences

Volume 52, Issue 24, 1993, Pages 1899-1907
Life Sciences

Minireview
Precoupling of GiGo-linked receptors and its allosteric regulation by monovalent cations

https://doi.org/10.1016/0024-3205(93)90630-LGet rights and content

Abstract

The ability of receptors (R) to activate G-proteins (G) is promoted by the binding of agonists, reflecting their induction of a receptor conformation which facilitates both the formation of a RG complex and guanine nucleotide exchange. Recent evidence from isolated membrane studies has indicated, however, that some receptors have the inherent ability to form RG complexes and promote GDP/GTP exchange in their unoccupied state. These receptors preferentially activate pertussis toxin-sensitive G-proteins (i.e. Gi/Go) and the interactions of R and G are modulated by monovalent cations (most notably Na+) both in the unoccupied and agonist-occupied states. Basal G-protein activation by such receptors is reduced both by increasing levels of cation and by antagonists which may act by inducing receptor conformations which are less favorable for RG complexation. This behavior conforms to the predictions of a ternary complex model of receptor function and can be considered in structural terms for those receptors such as the alpha-2 adrenergic receptor where ligand binding and G-protein activation regions have been proposed.

References (37)

  • A. Delean et al.

    J. Biol. Chem.

    (1980)
  • S.E. Senogles et al.

    J. Biol. Chem.

    (1987)
  • S. Uchida et al.

    Eur. J. Pharmacol.

    (1984)
  • J.R. Schlegel et al.

    Biochem. Pharmacol.

    (1986)
  • D.A. Greenberg et al.

    Brain Res.

    (1978)
  • D.A. Horstman et al.

    J. Biol. Chem.

    (1990)
  • B.F. O'Dowd et al.

    J. Biol. Chem.

    (1989)
  • E.M. Parker et al.

    J. Biol. Chem.

    (1991)
  • M.A. Kjelsberg et al.

    J. Biol. Chem.

    (1992)
  • S. Suryanarayana et al.

    J. Biol. Chem.

    (1991)
  • K. Aktories et al.

    Eur. J. Pharmacol.

    (1981)
  • K.A. Wregget et al.

    Mol. Pharmacol.

    (1981)
  • R.R. Neubig et al.

    Biochem.

    (1988)
  • E. Leung et al.

    Mol. Pharmacol.

    (1984)
  • E. Leung et al.

    Mol. Pharmacol.

    (1990)
  • M. Freissmuth et al.

    Biochem. J.

    (1991)
  • M. Freissmuth et al.
  • H. Matsui et al.

    J. Neurochem.

    (1985)
  • Cited by (29)

    • Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope

      2001, Biochemical and Biophysical Research Communications
    • Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB<inf>1</inf> cannabinoid receptor

      2000, Biochemical Pharmacology
      Citation Excerpt :

      [35S]GTPγS binding data obtained in studies of the μ-opioid receptor have demonstrated that different ionic conditions can affect both agonist and inverse agonist activity [20]. A theoretical discussion by Tian and Deth [21] describes the allosteric regulation of receptor–G-protein ternary complex by monovalent cations. In particular, increasing concentrations of Na+ favor the uncoupled state of the receptor to the G-protein such that agonist activation appears to be augmented.

    View all citing articles on Scopus
    View full text